Neoplastic development in plasma cells (Q35170940)

6 August 2017

1 reference

title

Neoplastic development in plasma cells (English)

1 reference

6 August 2017

Michael Potter

1

1 reference

6 August 2017

publication date

1 August 2003

1 reference

6 August 2017

published in

Immunological Reviews

1 reference

6 August 2017

volume

194

1 reference

6 August 2017

page(s)

177-195

1 reference

Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Plasma cells: finding new light at the end of B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Plasma cell differentiation requires the transcription factor XBP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Survival of long-lived plasma cells is independent of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Chromosomal translocations deregulating c-myc are associated with normal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Consistent loss of functional transforming growth factor β receptor expression in murine plasmacytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Apoptosis and tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Proliferation, cell cycle and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4aand p19ARF, is a candidate for the plasmacytoma susceptibility locus,Pctr1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

p16(Ink4a) in melanocyte senescence and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Interleukin-6 is a growth factor for nonmalignant human plasmablasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Essential role for oncogenic Ras in tumour maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

IL-6 transgenic mouse model for extraosseous plasmacytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

The role of p53 and pRB in apoptosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Bone turnover and biochemical markers in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Macrophage inflammatory protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

RANK-Fc: a therapeutic antagonist for RANK-L in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

RANK ligand and osteoprotegerin in myeloma bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Development and applications of the SCID-hu mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Induction of plasma-cell neoplasms and fibrosarcomas in BALB/c mice carrying diffusion chambers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

STAT3 activation, chemokine receptor expression, and cyclin-Cdk function in B-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

A matter of life and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

A growth-factor dependent B-cell hybridoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Abl: mechanisms of regulation and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Plasmacytoma induction in specific pathogen-free (SPF) bcl-2 transgenic BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Influence of long-term antigenic stimulation started in young C57BL mice on the development of age-related monoclonal gammapathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Monoclonal gammopathies of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

The distribution of plasma cells in naturally occurring periodontitis lesions in rats. A light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Dendritic cells enhance the differentiation of naïve B cells into plasma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Bone disease in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Immunocytochemistry reveals RANKL expression of myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

Clonal diversification of primary BALB/c plasmacytomas harboring T(12;15) chromosomal translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Distinctive developmental origins and specificities of murine CD5 B cells

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Kinetics of peritoneal B‐1a cells (CD5 B cells) in young adult mice

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Schistosoma mansoni: peritoneal plasmacytogenesis and polypoid transformation of mesenteric milky spots in infected mice

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

The role of c-myc in cell growth

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Reversible tumorigenesis by MYC in hematopoietic lineages

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Immunocytology of cultured IgM-forming cells of mouse. II. Purification of phagocytic cell factor and its role in antibody formation

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Colony formation in agar by murine plasmacytoma cells: Potentiation by hemopoietic cells and serum

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Interleukin 6 is essential for in vivo development of B lineage neoplasms

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

In vitro culture of primary plasmacytomas requires stromal cell feeder layers

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Rapid induction of IgM-secreting murine plasmacytomas by pristane and an immunoglobulin heavy-chain promoter/enhancer-driven c-myc/v-Ha-ras retrovirus

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Avian v-myc replaces chromosomal translocation in murine plasmacytomagenesis.

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Rapid viral induction of plasmacytomas in pristane-primed BALB-c mice.

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

The accelerating role of Abelson murine leukemia virus in murine plasmacytoma development: in vitro infection of spleen cells generates donor-type tumors after transfer to pristane-treated BALB/c mice

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

IgG1 plasmacytosis in interleukin 6 transgenic mice

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Long-term consequences of interleukin-6 overexpression in transgenic mice

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Bcl-2 tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene.

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing.

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

The influence of T cells on homogeneous immunoglobulins in sera of athymic nude mice during aging

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Bone marrow is a major site of long-term antibody production after acute viral infection

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Bone marrow and bone: a functional unit

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Quantitative histology of myeloma-induced bone changes

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Human bone marrow myeloma cells express RANKL

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

In vitro growth of human multiple myeloma: implications for biology and therapy

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Induction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane)

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Development of plasma-cell neoplasms in BALB/c mice after intraperitoneal injection of paraffin-oil adjuvant, heart-killed Staphylococcus mixtures

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Inhibition of plasmacytoma development in BALB/c mice by indomethacin

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene

1 reference

https://api.crossref.org/works/10.1034/J.1600-065X.2003.00061.X

7 January 2021

10.1034/J.1600-065X.2003.00061.X

Identifiers

DOI

1 reference

6 August 2017

1 reference